ELTX · Elicio Therapeutics, Inc. · Exempt Offerings
$1.71
+0.04 (+2.40%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”View the 10-Q filed Aug 13, 2026
Market Cap
$43.89M
Shares
26.28M
Volume · Oct 21
269.9K
Avg daily vol (3M)
305.93K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-03-29 | New | Biotechnology | $6,000,000 | $6,000,000 | 06b |
| 2024-01-05 | New | Biotechnology | $7,047,530 | $7,047,530 | 06b |
| 2020-06-23 | New | Biotechnology | $40,000,000 | $6,695,000 | 06b |
| 2020-01-27 | New | Biotechnology | $12,000,000 | $1,000,000 | 06b |
| 2020-01-13 | New | Biotechnology | $12,000,000 | $6,081,980 | 06b |
Showing 1–5 of 5 filings
Key facts
CIK
1601485
CUSIP
28657F103
13F (30d)
12 filings
12 filers
Visit website
Investor relations